The power of Boolean implication networks

Frontiers in Physiology

Volumn 3 JUL, Issue , 2012, Pages

  Sahoo, Debashis ^a  

^a Stanford California and Cofounder   (United States)

Author keywords

Bioinformatics; Cancer; Computational biology; Differentiation; Microarray analysis; Prognostic biomark ers; Stem cell; Systems biology

Indexed keywords

EID: 84866447870     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00276     Document Type: Short Survey

References (28)

1. Allison, M. (2012). Reinventing clinical trials. Nat. Biotechnol. 30, 41-49.
2. Arrowsmith, J. (2011). Trial watch: phase III and submission failures: 2007-2010. Nat. Rev. Drug Discov. 10, 87.
3. Basso, K., Margolin, A. A., Stolovitzky, G., Klein, U., Dalla-Favera, R., and Califano, A. (2005). Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390.
4. Bonneau, R., Facciotti, M. T., Reiss, D. J., Schmid, A. K., Pan, M., Kaur, A., Thorsson, V., Shannon, P., Johnson, M. H., Bare, J. C., Longabaugh, W., Vuthoori, M., Whitehead, K., Madar, A., Suzuki, L., Mori, T., Chang, D. E., Diruggiero, J., Johnson, C. H., Hood, L., and Baliga, N. S. (2007). A predictive model for transcriptional control of physiology in a free living cell. Cell 131, 1354-1365.
5. Bousquet, J., Anto, J. M., Sterk, P. J., Adcock, I. M., Chung, K. F., Roca, J., Agusti, A., Brightling, C., Cambon-Thomsen, A., Cesario, A., Abdelhak, S., Antonarakis, S. E., Avignon, A., Ballabio, A., Baraldi, E., Baranov, A., Bieber, T., Bockaert, J., Brahmachari, S., Brambilla, C., Bringer, J., Dauzat, M., Ernberg, I., Fabbri, L., Froguel, P., Galas, D., Gojobori, T., Hunter, P., Jorgensen, C.,Kauffmann, F., Kouril-sky, P., Kowalski, M. L., Lancet, D., Pen, C. L., Mallet, J., Mayosi, B., Mercier, J., Metspalu, A., Nadeau, J. H., Ninot, G., Noble, D., Oztürk, M., Palkonen, S., Préfaut, C., Rabe, K., Renard, E., Roberts, R. G., Samolin-ski, B., Schünemann, H. J., Simon, H. U., Soares, M. B., Superti-Furga, G., Tegner, J., Verjovski-Almeida, S., Wellstead, P., Wolkenhauer, O., Wouters, E., Balling, R., Brookes, A. J., Charron, D., Pison, C., Chen, Z., Hood,L.,and Auffray,C. (2011). Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med. 3, 43.
6. Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J. Jr., Chang, H. Y., van de Rijn, M., Shortliffe, L., and Weiss-man, I. L. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. U.S.A. 106, 14016-14021.
7. Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., Chau, I., and Van Cutsem, E. (2004). Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 35, 337-345.
8. Dalerba, P., Kalisky, T., Sahoo, D., Rajen-dran,P. S., Rothenberg,M. E., Leyrat, A. A., Sim, S., Okamoto, J., Johnston, D. M., Qian, D., Zabala, M., Bueno, J., Neff, N. F., Wang, J., Shel-ton, A. A., Visser, B., Hisamori, S., Shimono, Y., van de Wetering, M., Clevers, H., Clarke,M. F., and Quake, S. R. (2011). Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotech-nol. 29, 1120-1127.
9. Ferrell, J. E., Tsai, T. Y., and Yang, Q. (2011). Modeling the cell cycle: why do certain circuits oscillate? Cell 144, 874-885.
10. Glass, L., and Kauffman, S. A. (1973). The logical analysis of continuous, non-linear biochemical control networks. J. Theor. Biol. 39, 103-129.
11. Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., and Lander,E. S. (2011). Stochastic state transitions give rise to phe-notypic equilibrium in populations of cancer cells. Cell 146, 633-644.
12. Inlay, M. A., Bhattacharya, D., Sahoo, D., Serwold, T., Seita, J., Karsunky, H., Plevritis, S. K., Dill, D. L., and Weissman, I. L. (2009). Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 23, 2376-2381.
13. Jornsten, R., Abenius, T., Kling, T., Schmidt, L., Johansson, E., Nordling, T. E., Nordlander, B., Sander, C., Gennemark, P., Funa, K., Nils-son, B., Lindahl, L., and Nelander, S. (2011). Network modeling of the transcriptional effects of copy number aberrations in glioblas-toma. Mol. Syst. Biol. 7, 486. doi:10.1038/msb.2011.17
14. Lee, S. I., Dudley, A. M., Drubin, D., Silver, P. A., Krogan, N. J., Pe'er, D., and Koller, D. (2009). Learning a prior on regulatory potential from eQTL data. PLoS Genet. 5, e1000358. doi:10.1371/journal.pgen.1000358
15. Margolin, A. A., Nemenman, I., Basso, K., Wiggins, C., Stolovitzky, G., Dalla Favera, R., and Califano, A. (2006). ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7(Suppl. 1), S7.
16. Miller, R. A., Maloney, D. G., Warnke, R., and Levy, R. (1982). Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306, 517-522.
17. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carls-son, E., Ridderstråle, M., Laurila, E., Houstis, N., Daly, M. J., Patterson, N., Mesirov, J. P., Golub, T. R., Tamayo, P., Spiegelman, B., Lander, E. S., Hirschhorn, J. N., Altshuler, D., and Groop, L. C. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coor-dinately downregulated in human diabetes. Nat. Genet. 34, 267-273.
18. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
19. Sahoo, D., Dill, D. L., Gentles, A. J., Tibshirani, R., and Plevritis, S. K. (2008). Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol. 9, R157.
20. Sahoo, D., Dill, D. L., Tibshirani, R., and Plevritis, S. K. (2007). Extracting binary signals from microarray time-course data. Nucleic Acids Res. 35, 3705-3712.
21. Sahoo, D., Seita, J., Bhattacharya, D., Inlay, M. A., Weissman, I. L., Plevri-tis, S. K., and Dill, D. L. (2010). MiDReG:amethodof mining devel-opmentally regulated genes using Boolean implications. Proc. Natl. Acad. Sci. U.S.A. 107, 5732-5737.
22. Schadt, E. E., Linderman, M. D., Sorenson, J., Lee, L., and Nolan, G. P. (2010). Computational solutions to large-scale data management and analysis. Nat. Rev. Genet. 11, 647-657.
23. Scott,A.M.,Wolchok,J. D.,and Old,L.J. (2012). Antibody therapy of cancer. Nat. Rev. Cancer 12, 278-287.
24. Segal, E., Shapira, M., Regev, A., Pe'er, D., Botstein, D., Koller, D., and Friedman, N. (2003). Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166-176.
25. Shmulevich, I., and Kauffman, S. A. (2004). Activities and sensitivities in Boolean network models. Phys. Rev. Lett. 93, 048701.
26. Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Baja-monde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., and Norton, L. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metasta-tic breast cancer that overexpresses HER2.N. Engl. J. Med.344, 783-792.
27. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550.
28. Volkmer, J. P., Sahoo, D., Chin, R. K., Ho, P. L., Tang, C., Kurtova, A. V., Willingham, S. B., Pazhanisamy, S. K., Contreras-Trujillo, H., Storm, T. A., Lotan, Y., Beck, A. H., Chung, B. I., Alizadeh, A. A., Godoy, G., Lerner, S. P., van de Rijn, M., Short-liffe, L. D., Weissman, I. L., and Chan, K. S. (2012). Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc. Natl. Acad. Sci. U.S.A. 109, 2078-2083